We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $976M
1-Year Est. Return 66.76%
This Fund
S&P 500
This Quarter Est. Return
+9.74%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$2.61B
AUM Growth
+$649M
Cap. Flow
+$309M
Cap. Flow %
11.83%
Top 10 Hldgs %
33.84%
Holding
243
New
74
Increased
50
Reduced
36
Closed
67

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$33.3M
2
FNF icon
Fidelity National Financial
FNF
+$23.6M
3
MCD icon
McDonald's
MCD
+$19.7M
4
GAP
The Gap Inc
GAP
+$16.1M
5
HD icon
Home Depot
HD
+$15.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.2%
2 Healthcare 14.01%
3 Energy 12.98%
4 Consumer Discretionary 8.5%
5 Technology 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRS
151
DELISTED
Antares Pharma, Inc.
ATRS
$3.1M 0.12%
1,165,738
-325,000
-22% -$978K
SLXP
152
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.08M 0.12%
+25,000
New +$2.76M
LPNT
153
DELISTED
LifePoint Health, Inc.
LPNT
$3.04M 0.12%
49,000
MCD icon
154
McDonald's
MCD
$188B
$3M 0.12%
29,805
-195,195
-87% -$19.7M
BNNY
155
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
$2.83M 0.11%
+83,533
New +$2.81M
SIG icon
156
Signet Jewelers
SIG
$3.21B
$2.77M 0.11%
+25,000
New +$2.6M
AGN
157
CALL
DELISTED
Allergan Inc
AGN
$2.54M 0.1%
15,000
-85,000
-85% -$13.2M
CVEO icon
158
Civeo
CVEO
$342M
$2.5M 0.1%
+8,333
New +$2.49M
GMCR
159
DELISTED
KEURIG GREEN MTN INC
GMCR
$2.49M 0.1%
+20,000
New +$2.18M
MNST icon
160
Monster Beverage
MNST
$91.8B
$2.49M 0.1%
+420,000
New +$2.39M
ADNC
161
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$2.17M 0.08%
+182,089
New +$2.19M
ABMD
162
DELISTED
Abiomed Inc
ABMD
$2.11M 0.08%
+83,900
New +$1.95M
SFM icon
163
Sprouts Farmers Market
SFM
$7.6B
$1.96M 0.08%
+60,000
New +$1.87M
MNTA
164
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.81M 0.07%
+150,000
New +$1.77M
TLOG
165
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$1.67M 0.06%
286,801
-15,000
-5% -$85.1K
DVAX
166
DELISTED
Dynavax Technologies
DVAX
$1.66M 0.06%
104,438
-90,000
-46% -$1.36M
LCI
167
DELISTED
Lannett Company, Inc.
LCI
$1.66M 0.06%
+8,341
New +$1.31M
RPRX
168
DELISTED
Repros Therapeutics Inc.
RPRX
$1.6M 0.06%
92,318
-55,300
-37% -$902K
ACHC icon
169
Acadia Healthcare
ACHC
$2.66B
$1.59M 0.06%
+35,000
New +$1.54M
AEGR
170
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.44M 0.06%
45,000
+5,000
+13% +$186K
MDWD icon
171
MediWound
MDWD
$163M
$1.35M 0.05%
+17,143
New +$1.4M
ACN icon
172
Accenture
ACN
$116B
-106,000
Closed -$8.45M
AER icon
173
AerCap
AER
$23.2B
-75,000
Closed -$3.16M
ANF icon
174
Abercrombie & Fitch
ANF
$6.59B
-269,000
Closed -$10.4M
AR icon
175
Antero Resources
AR
$11.8B
-75,000
Closed -$4.7M

Similar funds

Kingdon Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Kingdon Capital Management held 243 positions worth $2.61B, up 33% from $1.96B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Kingdon Capital Management deployed $309M of net new capital in Q2 2014, opening 74 new positions and adding to 50 existing holdings. Its largest new stake was Micron Technology: 1,600,000 shares worth $52.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was McDonald's, an estimated $19.7M trimmed.

  • Kingdon Capital Management's largest Q2 2014 buy was Micron Technology: 1,600,000 shares worth $52.7M.
  • Kingdon Capital Management added most to Halliburton in Q2 2014, an estimated $40.1M increase.
  • Kingdon Capital Management's biggest Q2 2014 reduction was McDonald's, cutting an estimated $19.7M.
  • Kingdon Capital Management fully exited Citigroup in Q2 2014, selling an estimated $33.3M.
  • Kingdon Capital Management's ten largest holdings make up 34% of its $2.61B portfolio in Q2 2014.
  • Kingdon Capital Management opened 74 new positions and closed 67 in Q2 2014.
  • Kingdon Capital Management's portfolio value rose 33% quarter-over-quarter to $2.61B.

Based on Kingdon Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.